Rise across the board! TOP10 brands in the 27 billion insulin market released
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
Retatrutide/Tirzepatide/Cagri/Ghk-Cu 99% White Raw Power High Quality 2381089-83-2 Weight Loss Peptide
$178.7/G FOB
2026-07-14
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Novo Nordisk to Undergo Major Restructuring, Cutting 9,000 Jobs Worldwide
-
Sanofi Repurchases 2.3% of L'Oréal Shares
-
The largest investment in China! Sanofi to invest 1 billion euros to build a new insulin production base in Beijing
-
Germany's pharmaceutical strategy continues to be effective: Sanofi will invest 1.3 billion euros to produce insulin
-
Novo Nordisk acquires Cardior Pharmaceuticals
-
Eli Lilly Says It Opposes Use of Its Weight-Loss Drug as Beauty Cosmetic
-
Can Novo Nordisk's Weight Loss Drug Revolutionize the Pharmaceutical Industry?
-
Is Novo Nordisk a Better Investment Than Eli Lilly?
-
Will Novo Nordisk's Etavopivat Revolutionize Treatment for Sickle Cell Disease?
-
Unleashing the Potential: Sanofi's Immune Breakthrough and Diversified Growth Opportunities
Recommend Reading
-
Sun Pharma’s Secret Sauce: Solve the Specific, Win the Market
-
The Oral GLP-1 Cage Match: Orforglipron vs Rybelsus
-
Sun Pharma’s Winning Formula: Precision Over Expansion
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
What is Serine? (Amino Acid Function & Sources)
-
Cayman Chemical Product Catalog: Overview, Categories & Pricing
-
Multiple Positive Factors Support a Strong Rise in Styrene
-
Lithium carbonate shows rollercoaster market trend, upward signal may appear
-
Cost Decline and Supply Increase Lead to Fluctuating Price Drop in DOP in August